Wednesday, 12 October 2022

Mylan receives SEC recommendation for import and marketing of Delanamid for MDR-TB

Mylan receives SEC recommendation for import and marketing of Delanamid for MDR-TB
Mylan receives SEC recommendation for import and marketing of Delanamid for MDR-TB

Subject Expert committee of CDSCO recommends for grant of permission to import and market Delamanid Dispersible Tablets 25mg against pulmonary multi drug resistant tuberculosis (MDR-TB) in adults, adolescents, children and infants.

Rajesh Vagh Wed, 10/12/2022 - 11:12

source https://www.pharmatutor.org/pharma-news/2022/mylan-receives-sec-recommendation-for-import-and-marketing-of-delanamid-for-mdr-tb

No comments:

Post a Comment

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...